文献速递心外重症与机械循环支持

术前维生素K减少左心室辅助装置植入时输血

Preoperative Vitamin K Reduces Blood Transfusions at Time of Left Ventricular Assist Device Implant.
PubMed 文献 · Ann Thorac Surg · 2019-08-27

该回顾性研究纳入190例左心室辅助装置植入患者,比较术前24小时内接受两剂10mg静脉维生素K(n=128)与未接受维生素K(n=62)对围术期输血需求的影响。维生素K组血制品使用显著更低(P<.001),未用维生素K组再探查止血率(29.7% vs 13.6%,P=.023)和出院死亡率(16.2% vs 2.8%,P=.004)更高,但校正混杂因素后再探查率和死亡未达统计学显著。两组卒中和泵血栓无显著差异。

要点

  • 术前24小时内给予两剂10mg静脉维生素K与血制品使用显著降低相关(P<.001)。
  • 未用维生素K组再探查止血率和出院死亡率更高,但校正后无统计学显著。
  • 两组卒中和泵血栓率无显著差异。

核心结论

  • 术前给予维生素K可能有助于减少左心室辅助装置植入患者的血制品使用,且不增加卒中或泵血栓风险。

研究设计与样本

  • 回顾性研究,纳入190例符合标准的左心室辅助装置植入患者。
  • 患者分为未接受维生素K组(n=62)和术前24小时内接受两剂10mg静脉维生素K组(n=128)。

主要发现

  • 维生素K组血制品使用显著低于未用维生素K组(P<.001)。
  • 未用维生素K组再探查止血率29.7% vs 维生素K组13.6%(P=.023),出院死亡率16.2% vs 2.8%(P=.004)。
  • 校正年龄、性别、种族、BMI、INTERMACS分级、总胆红素、外科医生和手术年份后,再探查率和死亡未达统计学显著。
  • 两组卒中和泵血栓率无统计学显著差异。

临床怎么用

  • 对左心室辅助装置植入患者,可考虑术前24小时内给予两剂10mg静脉维生素K以减少围术期血制品使用。
  • 该干预未增加卒中或泵血栓风险,但需结合患者个体情况评估。

局限性

  • 回顾性设计,存在选择偏倚可能。
  • 两组手术年份存在显著差异(P<.001),可能影响结果。
  • 校正混杂因素后再探查率和死亡未达统计学显著,结论需谨慎解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Congestive heart failure patients have hepatic congestion and abnormal coagulation profiles, increasing perioperative bleeding at time of ventricular assist device implantation. This study examined the impact of the preoperative administration of vitamin K on perioperative blood transfusion requirements. METHODS: Retrospectively, 190 patients met inclusion criteria. Patients received no vitamin K (n = 62) or two 10-mg doses of intravenous vitamin K (n = 128) in the 24 hours before assist device implantation. Primary end points included transfusion requirements and reexploration rates for bleeding. Secondary outcomes were pump thrombosis and in-hospital mortality. RESULTS: Baseline characteristics were similar between the 2 groups, with slight differences (not statistically significant) noted in the Interagency Registry for Mechanically Assisted Circulatory Support profile and total bilirubin levels. The only significant difference noted was the year of implantation (P < .001). Blood product usage was significantly lower in the vitamin K group compared to the no vitamin K group (P < .001). Higher rates of reexploration for bleeding (29.7% vs 13.6%, P = .023) and death at hospital discharge (16.2% vs 2.8%, P = .004) were noted for the no vitamin K group compared with the vitamin K group. After adjusting for age, sex, race, body mass index, Interagency Registry for Mechanically Assisted Circulatory Support profile, total bilirubin, surgeon, and year of operation, reexploration rates and death did not achieve statistical significance. No statistically significant difference was observed in stroke and pump thrombosis rates between the 2 groups. CONCLUSIONS: Preoperative vitamin K administration may help reduce blood product use without any increased risk for strokes or pump thrombosis.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Bansal A, Chan J, Bansal A, et al. Preoperative Vitamin K Reduces Blood Transfusions at Time of Left Ventricular Assist Device Implant. Ann Thorac Surg. 2019. PMID: 31470010. doi:10.1016/j.athoracsur.2019.06.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。